Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa

Background. Lupus nephritis (LN) can be complicated with requirement for kidney replacement therapy and death. Efficacy of induction therapies using mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVCYC) has been reported from studies, but there is limited data in Africans comparing bot...

Full description

Bibliographic Details
Main Authors:	Phelisa Sogayise, Udeme Ekrikpo, Ayanda Gcelu, Bianca Davidson, Nicola Wearne, Ugochi Okpechi-Samuel, Theophilus Ifeanyichukwu Umeizudike, Innocent Ijezie Chukwuonye, Ikechi Okpechi
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	International Journal of Nephrology
Online Access:	http://dx.doi.org/10.1155/2020/2412396

Similar Items

Retrospective comparison of cyclophosphamide and mycophenolate mofetil in lupus nephritis at Groote Schuur Hospital nephrology unit
by: Sogayise, Phelisa
Published: (2021)

Blood pressure gradients and cardiovascular risk factors in urban and rural populations in Abia State South Eastern Nigeria using the WHO STEPwise approach.
by: Ikechi Gareth Okpechi, et al.
Published: (2013-01-01)

Prevalence of peritonitis and mortality in patients with ESKD treated with chronic peritoneal dialysis in Africa: a systematic review
by: Udeme Ekrikpo, et al.
Published: (2020-12-01)

Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
by: Bingileki F Lwezaula, et al.
Published: (2021-01-01)

A diverse array of genetic factors contribute to the pathogenesis of Systemic Lupus Erythematosus
by: Tiffin Nicki, et al.
Published: (2013-01-01)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
by: Oh Chan Kwon, et al.
Published: (2020-06-01)

Metabolic syndrome, the leptin gene and kidney disease in non-diabetic black South Africans
by: Okpechi, Ikechi Gareth
Published: (2014)

ESKD in sub-Saharan Africa: will governments now listen?
by: Ikechi G Okpechi
Published: (2017-04-01)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
by: Dong-Ni Chen, et al.
Published: (2018-01-01)

Diffuse proliferative crescentic lupus nephritis with normal renal function
by: Vibhanshu Gupta, et al.
Published: (2012-01-01)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
by: S. W. Olson, et al.
Published: (2017-01-01)

The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial
by: Lauren Galbraith, et al.
Published: (2014-11-01)

POS-243 THE VALUE OF AUTOANTIBODIES AS PREDICTORS FOR PROLIFERATIVE LUPUS NEPHRITIS CLASSES
by: N. LADHARI, et al.
Published: (2021-04-01)

07 Lessons from transplantation: Multitargeted therapy for proliferative lupus nephritis
by: Daniel Tak Mao Chan
Published: (2021-04-01)

Continuous ambulatory peritoneal dialysis: perspectives on patient selection in low- to middle-income countries
by: Wearne N, et al.
Published: (2017-01-01)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
by: Mina Rina, et al.
Published: (2012-07-01)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
by: Trivedi Hargovind L, et al.
Published: (2008-02-01)

Renal Mononuclear Phagocytes in Lupus Nephritis
by: Anne Davidson
Published: (2021-07-01)

Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India
by: D Sircar, et al.
Published: (2013-01-01)

Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis
by: Ross Sophia, et al.
Published: (2012-08-01)

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
by: Ikechi G Okpechi, et al.
Published: (2010-05-01)

Update on the Treatment of Glomerulonephritis in Adults in Low-to-Middle-Income Countries
by: Ikechi G. Okpechi, et al.
Published: (2018-07-01)

Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey
by: Chukwuonye II, et al.
Published: (2013-08-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Establishing Clinical Variables towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
by: Chalhoub, Nathalie E.
Published: (2019)

Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries
by: Ameh OI, et al.
Published: (2020-10-01)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
by: Dawn J. Caster, et al.
Published: (2021-02-01)

Comparison of two steroid regimens in induction therapy of proliferative lupus nephritis: A randomized controlled trial
by: Joyita Bharati, et al.
Published: (2019-01-01)

Management of Lupus Nephritis
by: Farah Tamirou, et al.
Published: (2021-02-01)

Pediatric lupus nephritis
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)

Management of Lupus Nephritis
by: Merkel F, et al.
Published: (2000-01-01)

19 Lupus nephritis
by: Liz Lightstone, et al.
Published: (2021-04-01)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
by: Robert Nee, et al.
Published: (2015-01-01)

Health-related quality of life in patients on hemodialysis and peritoneal dialysis
by: Ikechi G Okpechi, et al.
Published: (2013-01-01)

Socioeconomic Determinants, Regional Differences, and Quality of Nephrology Research in Africa
by: Jean Jacques Noubiap, et al.
Published: (2020-10-01)

Urinary biomarkers in lupus nephritis
by: Cristian C. Aragón, et al.
Published: (2020-01-01)

Individualizing Therapy in Lupus Nephritis
by: Yu An, et al.
Published: (2019-10-01)

The Role of Cytokine in the Lupus Nephritis
by: Yasunori Iwata, et al.
Published: (2011-01-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)

Current status of lupus nephritis
by: Ajay Jaryal, et al.
Published: (2017-01-01)